Last updated: 2026-11-14 21:39:20. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
CalciMedica, Inc. (CALC) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $1.21, with a market capitalization of $8.41M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1.00 to $36.00. This page covers its latest market performance, valuation, price trends and company information.
$8.41M | |
$1.31 | |
$1.35 | |
$1.20 | |
$1.22 | |
30.30K | |
82.88K | |
-- | |
$36.00 | |
$1.00 | |
-- | |
-- |
CalciMedica, Inc. (CALC) last closed at $1.21 as of 2026-11-14 00:46:00, down 0.82% ($0.01) from the previous close of $1.22.
During the latest regular trading session, CALC traded between $1.20 and $1.35, with a volume of 30.30K shares. The closing price was near the lower end and near the lower end of its 52-week range.
Over the past seven days, CalciMedica, Inc. (CALC) moved from $1.30 to $1.21, representing a decline of 6.92% ($0.09).
The stock traded between $1.16 and $1.61 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 44.93 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 0.6%
CALC is currently trading at $1.21, placing it 0.6% of the way from its 52-week low of $1.00 to its 52-week high of $36.00. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapeutics that treat serious illnesses driven by inflammatory and immunologic processes and direct cellular damage. Its product candidates act upon calcium release-activated calcium (CRAC) channels and would constitute a new class of drugs. Its product candidate is Auxora, a potent and selective intravenous formulated small molecule CRAC channel inhibitor containing the active compound zegocractin (formerly referred to as CM4620) that, in animal models, reduced acute epithelial and/or endothelial cell injury and inflammation in organs, such as the pancreas, lungs and kidneys. The company operates as one operating segment focused on developing and commercializing therapeutics in the U.S.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 12 |
| Exchange | NASDAQ |
| Company Website |
Latest news related to CalciMedica, Inc. and CALC stock.
Gainers SELLAS Life Sciences Gr (NASDAQ:SLS) stock rose 19.6% to $9.6 during Friday's pre-market session. The market value of their outstanding shares is at $1.6 billion. As per the news, the Q3 earnings report
CalciMedica Inc. (CALC) received an upgrade to Zacks Rank #2 (Buy) driven by upward revisions in earnings estimates. The company's consensus estimate has increased 63.2% over the past three months, positioning it in the top 20% of Zacks-covered stocks. The upgrade reflects improved earnings outlook that could translate into buying pressure and stock price appreciation in the near term.
Eligible investors can buy real shares of CalciMedica, Inc. (CALC) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
See US stocks with the highest market capitalization
Discover today's most actively traded US stocks
Browse today's leading gainers in the US stock market
Explore the cryptocurrencies with the highest market capitalization
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to CALC, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between CALC shares and USD.
CALC Shares to USD
1.00 CALC shares = 1.21 USD
Calculations are estimates based on the latest available price and are for reference only.
